Zoledronic Acid in the Prevention of Skeletal-related Events in Hormone Refractory and Hormone-sensitive Prostate Cancer Patients With Bone Metastases
Clinical trial NCT00219219 · COMPLETED
Trial details
- NCT number
- NCT00219219
- Sponsor
- Novartis
- Status
- COMPLETED
- Phase
- Phase 4
- Study type
- INTERVENTIONAL
- Start date
- 2003-09-01
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.